Literature DB >> 22822711

Medication overuse headache in school-aged children: more common than expected?

Fausta Piazza1, Matteo Chiappedi, Erika Maffioletti, Federica Galli, Umberto Balottin.   

Abstract

OBJECTIVE: To investigate the prevalence of medication overuse headache (MOH) in a group of children and adolescents seen for headache in a third-level center in Italy.
BACKGROUND: Epidemiological studies indicate a prevalence of MOH in children and adolescents between 0.3 and 0.5%; no data are available for the Italian population.
METHODS: We studied a group of first-seen children and adolescents (118 patients, 43.2% male and 56.8% female, mean age: 11.9 years). A detailed history was taken, using criteria defined by Olesen et al to assess the presence of MOH. Statistical correlations between demographic and diagnostic variables were assessed.
RESULTS: Eleven (9.3%) of our patients presented MOH; in the group with chronic daily headache, the prevalence raised to 20.8%. At follow up, after introduction of a more rationale treatment, most patients improved, but 2 of them reported a worsening of their headache.
CONCLUSIONS: We believe that a strong warning regarding medication overuse in headache therapy is essential for pediatricians and neuropsychiatrists.
© 2012 American Headache Society.

Entities:  

Keywords:  adolescence; child; chronic daily headache; medication overuse headache; prevalence

Mesh:

Year:  2012        PMID: 22822711     DOI: 10.1111/j.1526-4610.2012.02221.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  15 in total

1.  Accompanying migrainous features in pediatric migraine patients with restless legs syndrome.

Authors:  Melis Sohtaoğlu Sevindik; Seden Demirci; Baki Göksan; Aynur Özge; Feray Karaali Savrun; Hatice Onur; Veli Yıldırım; Ismail Simsek; Harika Ozhan; Derya Uludüz
Journal:  Neurol Sci       Date:  2017-07-01       Impact factor: 3.307

2.  [Economic effects of chronic pain in childhood and adolescence: self-assessment of health care costs for affected families before and after a multidisciplinary inpatient pain therapy].

Authors:  A Ruhe; J Wager; P Schmidt; B Zernikow
Journal:  Schmerz       Date:  2013-12       Impact factor: 1.107

Review 3.  The optimal management of headaches in children and adolescents.

Authors:  Joanne Kacperski; Marielle A Kabbouche; Hope L O'Brien; Jessica L Weberding
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

Review 4.  Medication overuse headache in children and adolescents.

Authors:  Matteo Chiappedi; Umberto Balottin
Journal:  Curr Pain Headache Rep       Date:  2014-04

Review 5.  Newly Approved Agents for the Treatment and Prevention of Pediatric Migraine.

Authors:  Joanne Kacperski; Andrew D Hershey
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

Review 6.  Medication overuse headache: history, features, prevention and management strategies.

Authors:  Joel R Saper; Arnaldo Neves Da Silva
Journal:  CNS Drugs       Date:  2013-11       Impact factor: 5.749

Review 7.  Medication-overuse headache: a review.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  J Pain Res       Date:  2014-06-26       Impact factor: 3.133

Review 8.  The evolution of headache from childhood to adulthood: a review of the literature.

Authors:  Fabio Antonaci; Cristina Voiticovschi-Iosob; Anna Luisia Di Stefano; Federica Galli; Aynur Ozge; Umberto Balottin
Journal:  J Headache Pain       Date:  2014-03-18       Impact factor: 7.277

9.  Visual-spatial training efficacy in children affected by migraine without aura: a multicenter study.

Authors:  Francesco Precenzano; Maria Ruberto; Lucia Parisi; Margherita Salerno; Agata Maltese; Beatrice Gallai; Rosa Marotta; Serena Marianna Lavano; Francesco Lavano; Michele Roccella
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-27       Impact factor: 2.570

10.  Rorschach Evaluation of Personality and Emotional Characteristics in Adolescents With Migraine Versus Epilepsy and Controls.

Authors:  Laura Balottin; Stefania Mannarini; Daniela Candeloro; Alda Mita; Matteo Chiappedi; Umberto Balottin
Journal:  Front Neurol       Date:  2018-03-20       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.